Dilution of Existing Shareholders Through Exercise of Stock Acquisition Rights
First written in FY2023. 10 of 11 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MaterialisedAnnual report
「As of the end of June 2026, the number of potential shares from stock options was 54,000, equivalent to 1.4% of the 3,677,657 issued shares.」
During the fiscal year, 20,000 shares were issued through the exercise of stock acquisition rights, and an event that could lead to dilution continued to occur. At the end of the fiscal year, potential shares declined from 74,000 to 54,000, and the proportion of total issued shares declined from 2.0% to 1.4%. - FY2026-H1MaterialisedAnnual report
「1 July 2025–31 December 2025 (Note) 1 20,000 3,715,550 3,415 580,031 3,415 396,905 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the interim accounting period, 20,000 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. An event that could lead to dilution continued to occur in practice. - FY2025MaterialisedAnnual report
「1 July 2024–30 June 2025 77,400 3,695,550 13,329 576,615 13,329 393,490」
During the fiscal year, 77,400 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. At the end of the fiscal year, potential shares totaled 74,000, equivalent to 2.0% of the total number of issued shares. - FY2025-H1MaterialisedAnnual report
「1 July 2024–31 December 2024 (Note) 27,400 3,645,550 4,698 567,984 4,698 384,859 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim accounting period, 27,400 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. - FY2024MaterialisedAnnual report
「1 July 2023–30 June 2024 40,700 3,618,150 6,936 563,286 6,936 380,161 (Note) Increase due to the exercise of stock acquisition rights.」
During the fiscal year, 40,700 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares and other figures. At the end of the fiscal year, potential shares totaled 158,000, equivalent to 4.4% of the total number of issued shares. - FY2024-Q3MaterialisedAnnual report
「1 January 2024 ～ 31 March 2024 (Note) 1,700 3,617,150 306 563,127 306 380,001 (Note) Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period, 1,700 shares were also issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. Events that could lead to dilution of existing shareholders continued to occur. - FY2024-Q2MaterialisedAnnual report
「1 October 2023–31 December 2023 18,000 3,615,450 3,076 562,821 3,076 379,695 (Note) Increase due to the exercise of stock acquisition rights.」
During the second-quarter accounting period, 18,000 shares were also issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. Events that could lead to dilution of existing shareholders continued to occur. - FY2024-Q1MaterialisedAnnual report
「1 July 2023–30 September 2023 20,000 3,597,450 3,395 559,745 3,395 376,619 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 20,000 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, stated capital and capital surplus. An event that could lead to dilution of existing shareholders actually occurred. - FY2023First statedAnnual report
「As of the end of June 2023, the number of potential shares from stock options was 199,000, equivalent to 5.6% of the 3,577,450 issued shares.」
The company describes the possibility that the exercise of stock acquisition rights granted to officers and employees could dilute existing shareholders' equity value and voting rights.